Cannabigerol (CBG): Therapeutic Potential and Safety Profile

Dr. Nicolette Natale
Dr. David Miles
Written by Dr. Nicolette Natale on 22 May 2025
Medically reviewed by Dr. David Miles on 22 May 2025

Cannabigerol (CBG) is gaining attention in the world of cannabinoids for its promising health benefits and potential therapeutic applications, particularly in terms of pain, inflammation, and mental health. Unlike its more famous relatives, tetrahydrocannabinol (THC) and Cannabidiol (CBD), CBG is often called the “mother cannabinoid” because it’s the precursor to several other cannabinoids during the cannabis plant’s growth cycle.

But what exactly can CBG do, and is it safe? Here’s what the latest research says.

Key takeaways:
  • CBG is a non-psychoactive cannabinoid with anti-inflammatory, antibacterial, and neuroprotective potential, according to early studies.
  • While generally considered safe, more research is needed to understand long-term side effects and its potential for drug interactions.
  • CBG may hold promise in addiction recovery, anxiety management, and other conditions where conventional treatments fall short.
a photo of cannabis leaves in the background, with the text

Introduction to Cannabigerol (CBG)

CBG is a naturally occurring cannabinoid found in trace amounts in the cannabis plant. In its acidic form—cannabigerolic acid (CBGA)—it serves as the chemical precursor to tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoids.

As cannabis matures, CBGA is enzymatically converted into these compounds, leaving only small amounts of CBG in the final plant.

How it works: The science behind CBG

CBG interacts with the body’s endocannabinoid system (ECS), binding to both CB1 and CB2 receptors.

  • CB1 receptors are primarily found in the brain and the peripheral nervous system. They are involved in sending messages from nerve to nerve, pain control, memory, metabolism, and the cardiovascular system.  
  • CB2 receptors are mostly found in immune cells and bodily tissues. They have been shown to regulate immune responses, inflammatory processes, and neuroimmune interactions.  

According to research, CBG may influence neurotransmitter signaling, reduce inflammation, and even offer neuroprotective benefits by modulating the activity of specific receptors and enzymes, including 5-HT1A and TRP channels.  

How is it consumed?

CBG is typically consumed in oil or capsule form, but it’s also available in tinctures, vape cartridges, topicals, and flower strains bred to retain high concentrations of the cannabinoid. As it’s found in low concentrations in most cannabis strains, manufacturers often extract it from young plants or use specially cultivated CBG-dominant varieties.

Potential health benefits of CBG

Early research has demonstrated numerous potential health benefits of CBG. Below, we’ll explore the research behind these claims and uncover what conditions this cannabinoid may show promise in treating.

Anti-inflammatory and antioxidant properties

Inflammation and oxidative stress are at the root of many diseases. Fortunately, studies have shown that CBG may have strong anti-inflammatory and antioxidant properties, potentially helping to manage conditions like chronic pain, inflammatory bowel disease (IBD), and neuroinflammation.  

Research has also demonstrated that individuals who use CBG predominant strains reported their pain was “much improved,” and CBG was 74% more effective than traditional pharmacological treatments.  

Anti-cancer effects

CBG may be beneficial in treating certain types of cancer due to its antioxidant, anti-inflammatory, and antitumor effects.  Its impacts on neuroinflammation have led to research into its potential therapeutic effects as an adjunctive treatment to glioblastoma, a deadly cancer of the brain. Based on multiple research findings, it may play a crucial role in destroying therapy-resistant glioblastoma stem cells, which are the root of cancer development and extremely resistant to various other treatments.  

It has shown similar promise in the treatment of melanoma, colorectal, breast, and prostate cancer, although further research is needed to determine its true therapeutic potential.  

Antibacterial properties

With the ever-growing development of antibiotic-resistant bacteria, it is crucial to find alternative treatments for these infections. Interestingly, CBG has shown potent antibacterial activity against a broad spectrum of bacteria and antibiotic-resistant strains like methicillin-resistant Staphylococcus aureus (MRSA). In a recent review, CBG was highlighted as a promising compound for fighting drug-resistant pathogens like MRSA.

Neuroprotective effects

Research suggests that CBG may offer neuroprotective effects through its interaction with the endocannabinoid system and other cellular pathways, particularly those linked to serotonin. In preclinical models, it has demonstrated the ability to reduce oxidative stress and support neuronal survival. It may also have neuroprotective properties in toxic and neurodegenerative diseases like multiple sclerosis, Huntington’s disease, and Parkinson’s disease.  

Mental health support

CBG may help reduce anxiety, depression, and support mood regulation through its effects on serotonin receptors. Although more studies in humans are needed, early animal research suggests anxiolytic effects without the psychoactive properties of THC.

According to one study, users reported that CBG was preferred over conventional medicine in 80% of individuals with depression and 78% of individuals with anxiety. Other research found that CBG effectively reduced global feelings of anxiety and stress.  

Safety profile and side effects

Current research indicates that CBG is generally well tolerated, with minimal side effects. However, like many cannabinoids, it may interact with other medications by affecting cytochrome P450 enzymes, which play a role in drug metabolism. Reported side effects are typically mild and may include dry mouth, drowsiness, or appetite changes.  

Is CBG addictive?

Currently, there is no evidence that CBG is addictive. Like CBD, it does not produce a “high” or activate the brain’s reward system in the same way that THC does, making its abuse potential extremely low.

Individuals with substance abuse issues or cannabis use disorder should speak with their medical team before starting any new substances with the potential for abuse, no matter how minimal.

CBG vs. CBD: Understanding the differences

While both CBG and CBD are non-psychoactive and interact with the endocannabinoid system, they differ in their mechanisms of action and potential benefits. CBG has a stronger affinity for CB1 and CB2 receptors, whereas CBD largely works by modulating the ECS indirectly. This may make CBG more effective for certain conditions like bacterial infections or neurodegeneration, though more research is needed.

CBG is legal in many parts of the United States because it falls under the USDA Farm Bill of 2018. This bill states that cannabinoids derived from hemp containing less than 0.3% THC are legal.  

However, its regulation is still evolving. Unlike CBD, which has FDA-approved medications like Epidiolex, CBG has yet to undergo extensive clinical trials and regulatory scrutiny. It is best to always check with local and federal laws to ensure the safe use of CBG.

Potential of CBG in addiction treatment and recovery

Because of CBG’s effects on reducing anxiety, depression, and regulating mood, it is possible that it may have a role in substance abuse treatment and recovery. Common symptoms associated with substance abuse withdrawal often include anxiety, depression, and alterations in mood, meaning CBG may have therapeutic effects in this area.

Additionally, there is a great deal of research on the potential of cannabidiol (CBD) to treat substance abuse disorders through its ability to reduce cravings, withdrawal symptoms, and relapse. Due to CBG’s similar structure, non-psychoactive properties, and effects on the ECS, it may also prove to be a promising adjunctive treatment for addiction disorder.

FAQs

Common questions about CBG

Is CBG psychoactive?

No, CBG is considered non-psychoactive. It does not produce the intoxicating effects or "high" commonly associated with THC. Instead, CBG interacts with cannabinoid receptors in a way that can subtly promote relaxation, mood balance, and focus without impairing cognitive function. This makes it an attractive option for individuals seeking therapeutic benefits without altered mental states.

What are the most common conditions people use CBG for?

People often turn to CBG for a variety of health concerns, including anxiety, chronic inflammation, digestive issues like inflammatory bowel disease (IBD), glaucoma, and bacterial infections. Some users also explore CBG for supporting brain health and managing symptoms of neurodegenerative diseases, based on its reported neuroprotective properties. However, while anecdotal evidence and animal research are encouraging, clinical research in humans is still emerging.

How effective is CBG compared to conventional medications for anxiety?

Current research on CBG’s effectiveness for anxiety is promising but preliminary. Early animal studies suggest that CBG interacts with serotonin receptors to help regulate mood, much like some traditional anxiolytic medications. However, conventional pharmaceuticals like selective serotonin reuptake inhibitors (SSRIs) have decades of clinical research supporting their use. At this time, CBG may serve as a complementary tool rather than a direct replacement for established anxiety treatments.

How does CBG compare to other cannabinoids in terms of efficacy?

CBG and other cannabinoids like CBD and THC share some overlapping therapeutic properties, but they also have unique strengths. According to research, CBG shows especially strong antibacterial, neuroprotective, and anti-inflammatory effects, sometimes outperforming other cannabinoids in these areas. Unlike THC, it does not cause intoxication, and compared to CBD, it may have a more direct interaction with the endocannabinoid system. That said, individual responses vary, and more direct comparative studies are needed to fully understand their differences.

Was this page helpful?

Your feedback allows us to continually improve our information

Resources:

  1. Russo EB, Cuttler C, Cooper ZD, Stueber A, Whiteley VL, Sexton M. Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms. Cannabis and Cannabinoid Research. 2021;7(5).
  2. Mackie K. Cannabinoid Receptors: Where They Are and What They Do. Journal of Neuroendocrinology. 2008;20 Suppl 1(s1):10-14.
  3. Borrelli F, Fasolino I, Romano B, et al. Beneficial Effect of the Non-Psychotropic Plant Cannabinoid Cannabigerol on Experimental Inflammatory Bowel Disease. Biochemical Pharmacology. 2013;85(9):1306-1316.
  4. Anderson BD, Sepulveda DE, Nachnani R, et al. High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model. Journal of Pharmacology and Experimental Therapeutics. Published online July 15, 2024:JPET-002204.
  5. Gugliandolo A, Pollastro F, Grassi G, Bramanti P, Mazzon E. In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid. International Journal of Molecular Sciences. 2018;19(7):1992.
  6. Di Giacomo V, Chiavaroli A, Recinella L, et al. Antioxidant and Neuroprotective Effects Induced by Cannabidiol and Cannabigerol in Rat CTX-TNA2 Astrocytes and Isolated Cortexes. International Journal of Molecular Sciences. 2020;21(10):3575.
  7. Baek SH, Han SD, Yook CN, Kim YC, Kwak JS. Synthesis and Antitumor Activity of Cannabigerol. Archives of Pharmacal Research. 1996;19(3):228-230.
  8. Lah TT, Majc B, Novak M, et al. The Cytotoxic Effects of Cannabidiol and Cannabigerol on Glioblastoma Stem Cells May Mostly Involve GPR55 and TRPV1 Signalling. Cancers. 2022;14(23):5918-5918.
  9. Lah TT, Novak M, Pena Almidon MA, et al. Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma. Cells. 2021;10(2):340.
  10. Park JH, Hwang YN, Na HH, et al. Cannabigerol Treatment Shows Antiproliferative Activity and Causes Apoptosis of Human Colorectal Cancer Cells. Journal of Pharmacopuncture. 2024;27(4):332-339.
  11. Lah TT, Novak M, Pena Almidon MA, et al. Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma. Cells. 2021;10(2):340.
  12. Schanknecht E, Bachari A, Nassar N, Piva TJ, Mantri N. Phytochemical Constituents and Derivatives of Cannabis sativa; Bridging the Gap in Melanoma Treatment. International Journal of Molecular Sciences. 2023;24(1):859-859.
  13. Li S, Li W, Malhi NK, et al. Cannabigerol (CBG): A Comprehensive Review of Its Molecular Mechanisms and Therapeutic Potential. Molecules (Basel, Switzerland). 2024;29(22):5471.
  14. Schanknecht E, Bachari A, Nassar N, Piva TJ, Nitin Mantri. Phytochemical Constituents and Derivatives of Cannabis sativa; Bridging the Gap in Melanoma Treatment. International Journal of Molecular Sciences. 2023;24(1):859-859.
  15. Echeverry C, Prunell G, Narbondo C, et al. A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT1A Receptors. Neurotoxicity Research. 2021;39(2):335-348.
  16. Stone NL, England TJ, O’Sullivan SE. Protective Effects of Cannabidivarin and Cannabigerol on Cells of the Blood–Brain Barrier Under Ischemic Conditions. Cannabis and Cannabinoid Research. Published online March 17, 2021.
  17. Fleisher-Berkovich S, Ventura Y, Amoyal M, et al. Therapeutic Potential of Phytocannabinoid Cannabigerol for Multiple Sclerosis: Modulation of Microglial Activation In Vitro and In Vivo. Biomolecules. 2023;13(2):376-376.
  18. Nachnani R, Raup-Konsavage WM, Vrana KE. The Pharmacological Case for Cannabigerol. The Journal of Pharmacology and Experimental Therapeutics. 2021;376(2):204-212.
  19. Mendiguren A, Aostri E, Rodilla I, Pujana I, Noskova E, Pineda J. Cannabigerol Modulates α2-adrenoceptor and 5-HT1A receptor-mediated Electrophysiological Effects on Dorsal Raphe Nucleus and Locus Coeruleus Neurons and Anxiety Behavior in Rat. Frontiers in Pharmacology. 2023;14.
  20. Cuttler C, Stueber A, Cooper ZD, Russo E. Acute Effects of Cannabigerol on Anxiety, Stress, and Mood: A double-blind, placebo-controlled, crossover, Field Tria. Scientific Reports. 2024;14(1):16163.
  21. United States Department of Agriculture (2019). Executive Summary of New Hemp Authorities.
  22. Prud’homme, M., Cata, R., & Jutras-Aswad, D. (2015). Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence. Substance Abuse: Research and Treatment, 9, 33–38.

Activity History - Last updated: 22 May 2025, Published date:


Reviewer

David is a seasoned Pharmacist, natural medicines expert, medical reviewer, and pastor. Earning his Doctorate from the Medical University of South Carolina, David received clinical training at several major hospital systems and has worked for various pharmacy chains over the years. His focus and passion has always been taking care of his patients by getting accurate information and thorough education to those who need it most. His motto: "Good Information = Good Outcomes".

Activity History - Medically Reviewed on 21 May 2025 and last checked on 22 May 2025

Medically reviewed by
Dr. David Miles

Dr. David Miles

PharmD

Reviewer

Recovered Branding BG
Ready to talk about treatment? Call today. (833) 840-1202
Helpline Information

Calls to numbers marked with (I) symbols will be answered or returned by one of the treatment providers listed in our Terms and Conditions, each of which is a paid advertiser.

In calling the helpline you agree to our Terms and Conditions. We do not receive any fee or commission dependent upon which treatment or provider a caller chooses.

There is no obligation to enter treatment.

Access State-Specific Provider Directories for detailed information on locating licensed service providers and recovery residences in your area.

For any specific questions please email us at info@recovered.org

Related topics

Delta-9 THC

6 minutes read